| Patents for C12P 21 - Preparation of peptides or proteins (112,499) | 
|---|
| 01/08/1992 | EP0465008A2 A monoclonal antibody recognizing human pancreatic prophospholipase A2 | 
| 01/08/1992 | EP0464867A1 Fusion proteins of interleukin-alpha with hirudin | 
| 01/08/1992 | EP0464590A2 Inhibition of coloration of human serum albumin | 
| 01/08/1992 | EP0464533A1 Fusionproteins with parts of immunoglobulins, their production and use | 
| 01/08/1992 | EP0464311A2 Anti-virus substance and process for producing the same | 
| 01/08/1992 | EP0464175A1 Extracellular form of the human fibroblast growth factor receptor | 
| 01/08/1992 | EP0464147A1 Matrix metalloproteinase inhibitor peptides | 
| 01/08/1992 | EP0464022A1 Insulinotropic hormone | 
| 01/08/1992 | CN1057655A Ws7622a mono-or di-sulfate, process for preparation thereof and use thereof | 
| 01/07/1992 | WO1992001041A1 A cDNA ENCODING THE RAT D1 DOPAMINE RECEPTOR LINKED TO ADENYLYL CYCLASE ACTIVATION AND EXPRESSION PRODUCT | 
| 01/07/1992 | WO1992001001A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes | 
| 01/07/1992 | US5079343 AIDS diagnosis | 
| 01/07/1992 | US5079229 Modified eglin proteins | 
| 01/07/1992 | US5079173 Hepatitis Diagnosis | 
| 01/07/1992 | US5079163 Recombinant ricin toxin fragments | 
| 01/07/1992 | US5079152 Antibody combining sites that exhibit stereoselective synthase activity, and methods using the same | 
| 01/07/1992 | US5078996 Genetic engineering, anticancer agents | 
| 01/07/1992 | CA2086761A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes | 
| 01/07/1992 | CA2086411A1 Cdna encoding the rat d1 dopamine receptor linked to adenylyl cyclase activation and expression product | 
| 01/07/1992 | CA1293938C Purification of synthetic oligomers | 
| 01/07/1992 | CA1293927C Bonding-inducing composition containing enamel matrix | 
| 01/03/1992 | WO1992000319A1 Human meg-csf protein and methods | 
| 01/03/1992 | CA2086248A1 Human meg-csf protein and methods | 
| 01/02/1992 | EP0463998A2 Immunological detection of triasulfuron | 
| 01/02/1992 | EP0463615A1 Process for the production of GnRH-decapeptides | 
| 01/02/1992 | EP0463393A2 A mutant of bacillus subtiles and a method of producing surfactin with the use of the mutant | 
| 01/02/1992 | EP0463115A1 Acetylated heterologous polypeptides. | 
| 01/02/1992 | EP0463110A1 Monoclonal antibodies for metallic cations | 
| 01/02/1992 | EP0463109A1 Recombinant alpha-galactosidase, a therapy for fabry disease | 
| 01/02/1992 | EP0463081A1 Hormone response element compositions and assay | 
| 01/02/1992 | EP0463080A1 Cd8-based pharmaceuticals | 
| 01/02/1992 | EP0463073A1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA | 
| 01/02/1992 | EP0463072A1 Novel insulin compounds. | 
| 01/02/1992 | EP0463070A1 A process for producing pentapeptides and intermediates for use in the synthesis. | 
| 01/02/1992 | EP0463064A1 Neuronal nicotinic acetylcholine receptor compositions containing the beta4 subunit | 
| 01/02/1992 | EP0463059A1 Allergenic proteins from ragweed and uses therefor | 
| 01/02/1992 | EP0463053A1 Production and use of anthelmintic agents and protective immunogens | 
| 01/02/1992 | EP0463037A1 Human macrophage migration inhibitory factor | 
| 01/02/1992 | EP0255823B1 Dna encoding adasp?113 bd and adlys?46 , asp?113 bd thaumatin i | 
| 01/02/1992 | EP0196319B1 Retroviral polypeptides associated with human cellular transformation | 
| 01/02/1992 | EP0189431B1 Process for purifying a protein | 
| 01/02/1992 | EP0183776B1 A process for isolating a substantially insoluble polypeptide using non-ionic detergents. | 
| 01/02/1992 | EP0179152B1 Diagnostic system for the detection of cytomegalovirus | 
| 12/31/1991 | WO1992000328A1 Non-a non-b sequences | 
| 12/31/1991 | US5077392 Process for activation of recombinant protein produced by prokaryotes | 
| 12/31/1991 | US5077388 Purification of human interleukin-4 from a secreted escherichia coli mutant | 
| 12/31/1991 | US5077216 Monoclonal antibodies specific for a human mononculear phagocyte-specific antigen | 
| 12/31/1991 | US5077195 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor | 
| 12/31/1991 | US5077193 Diagnostic kits | 
| 12/31/1991 | CA2072092A1 Non-a non-b sequences | 
| 12/31/1991 | CA2043618A1 Method for the production of gnrh-decapeptides | 
| 12/30/1991 | CA2045876A1 Immunological detection methods | 
| 12/29/1991 | WO1992000375A1 Sex determining gene | 
| 12/29/1991 | CA2085102A1 Sex determining gene | 
| 12/28/1991 | CA2058041A1 Anti-igf-ii monoclonal antibody | 
| 12/27/1991 | EP0462721A2 Novel Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from Bacillus thuringiensis isolates | 
| 12/27/1991 | EP0462627A1 Antigens and peptides of lav. | 
| 12/27/1991 | EP0462623A1 Monoclonal antibodies to human immune interferon | 
| 12/27/1991 | EP0462551A1 HIV GP120 monoclonal antibodies | 
| 12/27/1991 | EP0462531A2 Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain | 
| 12/27/1991 | EP0462277A1 Glycoprotein of human origin, physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient | 
| 12/27/1991 | EP0462246A1 Oligomeric immunoglobulins | 
| 12/27/1991 | EP0462215A1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS | 
| 12/27/1991 | EP0462147A1 Monoclonal antibodies to synthetic pyrethroids and method for detecting the same | 
| 12/27/1991 | EP0462111A1 Homing sequences and their uses | 
| 12/26/1991 | WO1992000318A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof | 
| 12/26/1991 | WO1991019810A1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease | 
| 12/26/1991 | WO1991019801A1 RECOMBINANT 47 AND 31kD COCOA PROTEINS AND PRECURSOR | 
| 12/26/1991 | WO1991019800A1 RECOMBINANT 21 kD COCOA PROTEIN AND PRECURSOR | 
| 12/26/1991 | WO1991019787A1 Protease nexin-i variants | 
| 12/26/1991 | WO1991019785A1 THE RETROVIRUS SIVcpz-ant AND ITS USES | 
| 12/26/1991 | WO1991019744A1 Hepatitis c virus antigen polypeptide, production thereof, and detection of antibody | 
| 12/26/1991 | WO1991019740A1 IgG-BINDING PROTEIN | 
| 12/26/1991 | WO1991019419A1 Pasteurella multocida toxoid vaccines | 
| 12/26/1991 | WO1991017773A3 New protein-polycation conjugates | 
| 12/26/1991 | WO1991017187A3 A 35kd tumor associated protein antigen: uses and methods of detection | 
| 12/26/1991 | CA2085980A1 Protease nexin-i variants | 
| 12/26/1991 | CA2085370A1 The retrovirus siv cpz-ant and its uses | 
| 12/26/1991 | CA2084992A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof | 
| 12/26/1991 | CA2084059A1 Recombinant 47 and 31kd cocoa proteins and precursor | 
| 12/26/1991 | CA2084058A1 Recombinant 21 kd cocoa protein and precursor | 
| 12/26/1991 | CA2044876A1 Tryptophan promoters | 
| 12/25/1991 | CN1057295A Process for isolation and expression of human ciliary neuronotrophic factor by recombinant dna technology | 
| 12/25/1991 | CN1057294A Method for recombinant production of hirudins | 
| 12/25/1991 | CN1057268A Crystalline interleukin-4 | 
| 12/24/1991 | US5075423 Purification of protein a by affinity chromatography followed by anion exchange | 
| 12/24/1991 | US5075236 Method of detecting kawasaki disease using anti-tumor necrosis antibody | 
| 12/24/1991 | US5075223 Recombinant dna, process for the production thereof and the use thereof | 
| 12/24/1991 | US5075221 Stabilized extraction composition containing a sulfhydryl-containing reducing agent and its use in chlamydial and gonococcal determinations | 
| 12/24/1991 | US5075219 Monoclonal antibody which recognizes a specific glycoprotein of a human milk-fat globule membrane mucin antigen and said mucin antigen | 
| 12/24/1991 | US5075211 Complexing antibodies with oligopeptides, blood screening | 
| 12/24/1991 | CA1293591C Peptide substrates for detecting virus-specified protease activity | 
| 12/23/1991 | WO1992000100A1 Improved ascites production of monoclonal antibodies using an immunosuppressive anti-cd4-related antibody | 
| 12/23/1991 | CA2085586A1 Ascites production of monoclonal antibodies using an immunosuppressive anti-cd4-related antibody | 
| 12/23/1991 | CA2044908A1 In vivo targeting with bifuncitonal antibodies | 
| 12/22/1991 | CA2044858A1 Method of treating bladder cancer cells | 
| 12/21/1991 | WO1991019817A1 EXPRESSION VECTORS CONTAINING THE HIV nef GENE TO ENHANCE REPLICATION EFFICIENCY | 
| 12/21/1991 | WO1991019729A1 Nucleic acid probes and protein probes | 
| 12/21/1991 | CA2085880A1 Expression vectors containing the hiv nef gene to enhance replication efficiency | 
| 12/21/1991 | CA2059559A1 Nucleic acid probes and protein probes |